Company

Syngen Biotech Co. Ltd

Headquarters: Tainan City, Taiwan

TWSE: 8279 -0.76%

Market Cap

TW$4.27 Billion

TWD as of July 1, 2024

US$131.1 Million

Market Cap History

Syngen Biotech Co. Ltd market capitalization over time

Evolution of Syngen Biotech Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Syngen Biotech Co. Ltd

Detailed Description

Syngen Biotech Co., Ltd. operates as a biotech company in Taiwan. The company manufactures and sells active pharmaceutical ingredients, including Mupirocin, an antibiotic against gram-positive bacteria that is used for the topical treatment of superficial infections, such as impetigo and infections, as well as to control infected eczema, wounds, and burns; and nutraceutical ingredients comprising probiotics, medicinal fungi, and entomogenous fungi. It also offers biology fermentation, biology agriculture and aquaculture, and functional food products. The company was founded in 1999 and is based in Tainan City, Taiwan.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Syngen Biotech Co. Ltd has the following listings and related stock indices.


Stock: TWSE: 8279 wb_incandescent

Details

Headquarters:

No.154, Kaiyuan Road

Sinying District

Tainan City, 73055

Taiwan

Phone: 886 6 5058 168

Fax: 886 6 5058 169